ЮЗ СОҲА ИНФАНТИЛ ГЕМАНГИОМАЛАРИНИ МЕДИКАМЕНТОЗ ДАВОЛАШ НАТИЖАЛАРИ
PDF
DOI

How to Cite

КАРИМОВ , М., ДУШАЕВА, Н., & НУРМАТОВА, Х. (2024). ЮЗ СОҲА ИНФАНТИЛ ГЕМАНГИОМАЛАРИНИ МЕДИКАМЕНТОЗ ДАВОЛАШ НАТИЖАЛАРИ. Journal of Experimental Studies, 2(2), 32–39. Retrieved from https://imfaktor.com/joes/article/view/1055

Abstract

Гемангиома – яхши сифатли қон-томир хавфсиз ўсмаси бўлиб, асосан чақалоқликнинг илк 3 ҳафталигида қизил доғ кўринишида кузатилиб, тез ўсиши ва атроф тўқималарга инвазияланиши билан характерланади. Янги туғилган болаларнинг 3-11% учрайди, уларнинг 70%и бош ва бўйин соҳасида кузатилади. Қиз болалар ва ўғил болаларга нисбатан 3,5 марта кўпроқ кузатилади.

Юз соҳасида жойлашган гемангиомалар дисморфофобия, косметик нуқсон каби муоммоларни келтириб чақириб ҳатто беморни жамиятдан ажралишга олиб келади. Ушбу мақолада эмизикли даврдаги болаларда юз соҳада жойлашган тери гемангиомани кечиши, клиникаси, тарқалиши, замонавий ташхисоти, классификацияси ва замонавий даволаш усуллари, шунингдек, медикаментоз даво натижалари баён қилинган. Тадқиқотда 2020-2024 йиллар оралиғида  амбулатор даволанган 60 нафар беморларнинг даво натижалари таҳлил қилинган. Даволашда эмизикли даврдаги болаларни илк мурожаат этган даврини инобатга олган ҳолда даво натижалари ўзаро солитрилма таҳлил қилинган.

PDF
DOI

References

Goto, K., Ozeki, M., Yasue, S., Endo, S., & Fukao, T. (2020). Retrospective study of propranolol 2 or 3 mg/kg/day for infantile hemangioma. Pediatrician International, 62(6), 751-753.

Karimov M. A, Dzhamalov Zh. B, Abdulkhakimov S. A., Irisova L. F, Nurmatova Kh. H, & Ikramova F.D. (2024). Results of Drug Treatment of Hemangiomas of the Scalp in Children and Infants. Miasto Przyszłości, 44, 344–348. Retrieved from https://miastoprzyszlosci.com.pl/index.php/mp/article/view/2438

Karimov M. A, Mirzakarimov B. N, Dzhabborova M. T, Abdusamatova N. K, Ubaydullaeva D. U, & Nurmatova H. H. (2024). Results of Drug Treatment of Facial Hemangioma in Infantry. Best Journal of Innovation in Science, Research and Development, 3(1), 335–339. Retrieved from https://www.bjisrd.com/index.php/bjisrd/article/view/1431

Karimov M.A, Sadikov R.R, Makhmudova R.Y, Yakubov A.A, Turgunov Z, & Rachimberdieva G.A. (2023). Comparative Effectiveness of Treatment of Oral Hemangiomas with Ir-Lasers. Eurasian Scientific Herald, 20, 5–11. Retrieved from https://www.geniusjournals.org/index.php/esh/article/view/4091

Karimov M.A. New approaches in the diagnosis of oral hemangiomas American Journal of Medical Sciences and Pharmaceutical Research Doi: https://doi.org/10.37547/TAJMSPR/ Volume02 Issue08 August 20, 2020 | Pages: 50-57

Karimov M.A., Kholmirzaev O.N., Inomov Q.S., Karimkulov N.A., Mirzakarimov B.N. (2023). RESULTS OF PROPRONALOL TREATMENT OF FACIAL HEMANGIOMAS. INTERNATIONAL BULLETIN OF MEDICAL SCIENCES AND CLINICAL RESEARCH, 3(9), 5–10. https://doi.org/10.5281/zenodo.8324960

Karimov M.A., Sadikov R.R., Karimkulov N.A., Nurmatova X.X. (2023). COMPARATIVE EFFECTIVENESS OF TREATMENT OF ORAL MUCOSAL HEMANGIOMAS WITH IQ-LASERS. INTERNATIONAL BULLETIN OF APPLIED SCIENCE AND TECHNOLOGY, 3(7), 44–49. https://doi.org/10.5281/zenodo.8128871

Karimov M.A., Sadikov R.R., Nurmatova Kh.H. (2023). RESULTS OF COMPREHENSIVE TREATMENT OF ORAL HEMANGIOMA. EURASIAN JOURNAL OF ACADEMIC RESEARCH, 3(4), 102–107. https://doi.org/10.5281/zenodo.7805172

Leaute-Labrese K, Prey S, Ezzedine K. Infantile hemangioma: Part I. Pathophysiology, epidemiology, clinical features, life cycle and associated structural abnormalities. J. Eur. acad. Dermatol. Venereol. 2011; 25 (11): 1245–53. doi: 10.1111/j.14683083.2011.04102. x.

M. A. Karimov, D. Z. Mamarasulova, R. R. Sadikov, KH. H. Nurmatova RESULT OF TREATMENT OF HEMANGIOMAS OF THE ORAL CAVITY Doctoral Bulletin No. 4 (97)-2020 p. 162-165.

M. A., Karimov, Sadikov R. R., and Nurmatova X. X. 2023. “Prevalence and Treatment Results of Oral Hemangiomas in Children”. Middle European Scientific Bulletin 38 (July):70-71. https://cejsr.academicjournal.io/index.php/journal/article/view/1834.

M.A.Karimov, R.R.Sadikov, Kh.H.Nurmatova. (2023). OGIZ BOSHLIGI GEMANGIOMALARINI COMPLEX DAVOLASH NATIZHALARI. EURASIAN JOURNAL OF ACADEMIC RESEARCH, 3(4), 102–107. https://doi.org/10.5281/zenodo.7805172

M.A.Karimov, R.R.Sadikov, M.M. Mirzaolimov, B.N. Mirzakarimov, X.X.Nurmatova, & G.R. Rakhmonova. (2023). RESULTS OF COMPLEX TREATMENT OF ORAL HEMANGIOMAS. European Scholar Journal, 4(4), 32-35. Retrieved from https://www.scholarzest.com/index.php/esj/article/view/3375

Wassef M., Blei F., Adams D., Alomari A., Baselga E., Berenstein A., et al.; ISSVA Board and Scientific Committee. Vascular Anomalies Classification: Recommendations from the International Society for the Study of Vascular Anomalies. Pediatrics. 2015; 136(1): e203--14. doi: 10.1542/peds.2014-3673.

М.А.Каримов, Р.Р.Садиков, Х.Х.Нурматова. (2023). БОЛАЛАРДА ОҒИЗ БЎШЛИҒИ, БОШ ВА ЮЗ – ЖАҒ СОҲА ГЕМАНГИОМАЛАРИ. YOSH OLIMLAR ILMIY-AMALIY KONFERENSIYASI, 2(03), 90–91. https://doi.org/10.5281/zenodo.7949716

М.А.Каримов, Р.Р.Садиков, Х.Х.Нурматова. (2023). ОҒИЗ БЎШЛИҒИ ВА УНИНГ АТРОФИ СОҲА ГЕМАНГИОМАЛАРИ. YOSH OLIMLAR ILMIY-AMALIY KONFERENSIYASI, 2(03), 88–89. https://doi.org/10.5281/zenodo.7949703

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.